BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Yuhan to co-develop and sell GI Innovation's biologic for treatment of allergic diseases

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : July 1, 2020, 13:42 | Updated : July 1, 2020, 13:42
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Yuhan]

SEOUL -- Yuhan, a pharmaceutical and chemical company in South Korea, signed a contract with GI Innovation, a domestic bio-venture company, to co-develop and sell GI-301 in overseas markets except for Japan. GI-301 is a biologic for the treatment of allergic diseases, including atopic dermatitis and chronic idiopathic.

Yuhan said in a regulatory filing that the contract amount is 20 billion won ($16.6 million). If Yuhan develops and sells GI-301 directly, it will pay 89 billion won in milestones and 1.3 trillion won in loyalty by stage according to sales. Yuhan can transfer technology to a global pharmaceutical company in the process of developing GI-301. After transferring technology overseas, the two companies will equally share profits.

The immune system overreacts to an allergen by producing antibodies called Immunoglobulin E (IgE), a type of antibody that travels to cells. Allergic diseases are caused by the secretion of histamine when IgE is combined with fat cells or porcupines. GI-301 is a fusion protein that binds to IgE and prevents it from being combined with obesity cells.

GI Innovation will conduct phase 2 clinical trials in 2021. Yuhan said that in pre-clinical trials on monkeys, GI-301 showed superior inhibitory effects over omalizumab sold under the trade name Xolair, which has been used to control severe allergic asthma, which does not respond to high doses of corticosteroids and less widely for chronic spontaneous urticaria.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Yuhan-Kimberly makes foray into adult cosmetics market with anti-pollution skin care brand.
    Yuhan-Kimberly makes foray into adult cosmetics market with …
  • .     Yuhan secures drug technology transfer deal from American company Processa.
    Yuhan secures drug technology transfer deal from Americ…
  • .[FOCUS] Sales of Huggies baby products banned in S. Korea for excessive methanol.
    [FOCUS] Sales of Huggies baby products banned in S. Korea fo…
  • .Yuhan and Gilead agree to develop novel therapeutic candidates for NASH .
    Yuhan and Gilead agree to develop novel therapeutic candidat…

Real Time Photo News

  • .Girl band (G)I-DLE shrinks size to five members after school bullying controversy.

    Girl band (G)I-DLE shrinks size to five members after school bullying controversy

  • .Singer-actress IU reveals release schedule for album LILAC.

    Singer-actress IU reveals release schedule for album 'LILAC'

  • .S. Korea to build state-run K-pop concert hall for unaffordable online performances .

    S. Korea to build state-run K-pop concert hall for unaffordable online performances

  • .BLACKPINK member Rosé to release solo album in March.

    BLACKPINK member Rosé to release solo album in March

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

Latest News

more+

  • Young woman faces trial for eating hamberger and insulting train passenger
  • Girl band (G)I-DLE shrinks size to five members after school bullying controversy
  • S. Korean companies to build combined cycle power plant in Thailand
  • Transparent LED film displays videos and images at official venue of Busan film festival
  • Daredevil surfers to be fined for ignoring storm warning
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view